- Home
- ADXN vs PIII Comparison
ADXN vs PIII Comparison
Compare ADXN & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADXN | PIII |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 10.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADXN | PIII |
|---|---|---|
| Price | $7.26 | $2.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.25 |
| AVG Volume (30 Days) | 3.0K | ★ 75.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $86.57 | N/A |
| Revenue Next Year | N/A | $14.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.51 | $0.15 |
| 52 Week High | $12.05 | $11.30 |
Technical Indicators
Market Signals| Indicator | ADXN | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 60.01 |
| Support Level | $7.52 | $1.52 |
| Resistance Level | $8.04 | $3.85 |
| Average True Range (ATR) | 0.24 | 0.43 |
| MACD | 0.01 | 0.16 |
| Stochastic Oscillator | 63.10 | 52.91 |
Price Performance
Historical ComparisonAbout ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.